# Intravenous Dexamethasone for Ropivacaine Axillary Block

> **NCT02862327** · PHASE3 · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Besancon** · enrollment: 99 (actual)

## Conditions studied

- Postoperative Pain
- Anesthesia
- Forearm Injuries

## Interventions

- **DRUG:** intravenous dexamethasone
- **DRUG:** intravenous placebo
- **DRUG:** perineural ropivacaine
- **OTHER:** ultrasound guidance

## Key facts

- **NCT ID:** NCT02862327
- **Lead sponsor:** Centre Hospitalier Universitaire de Besancon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-01
- **Primary completion:** 2017-03-16
- **Final completion:** 2017-09-16
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2018-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02862327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02862327, "Intravenous Dexamethasone for Ropivacaine Axillary Block". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02862327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*